The Impact of Concomitant Ulcerative Colitis on the Clinical Course in Patients with Primary Sclerosing Cholangitis: An Investigation Using a Nationwide Database in Japan

Abstract

Introoduction: Primary sclerosing cholangitis (PSC) is a rare disease, especially in Asian countries. PSC often develops during ulcerative colitis (UC). Little is known about the severity of PSC in patients with UC. Thus, this study aimed to investigate the impact of concomitant UC on the clinical course of patients with PSC using a nationwide database in Japan. Methods: We collected data on patients who were admitted for PSC using a nationwide database and divided eligible admissions according to concomitant UC (PSC-UC group vs. PSC alone group). We conducted propensity score matching and compared the rates of liver transplantation, biliary drainage, and other clinical events between the two groups. We also conducted a multivariate analysis to identify the clinical factors that affect biliary drainage, cholangiocarcinoma, and liver transplantation. Results: We enrolled 672 patients after propensity score matching. The rate of liver transplantation in the PSC-UC group was lower than that in the PSC alone group (2.2% vs. 5.4%, P = 0.002), whereas the rate of biliary drainage did not differ between the two groups (38.1% vs. 33.8%, P = 0.10). On multivariate analysis, concomitant UC was identified as a clinical factor that decreased the risk of liver transplantation (odds ratio = 0.40, 95% confidence interval: 0.23–0.68, P = 0.0007). Discussion/Conclusion: Concomitant UC in patients with PSC may decrease the risk of liver transplantation. The milder disease activity of PSC with UC is more likely compared to that of PSC without UC.

Clinical Utilization of Generic Drugs and Biosimilars for Ulcerative Colitis Treatment: Insights from a Nationwide Database Study in Japan

“…Previously, we conducted clinical research on lower gastrointestinal diseases using big data analytics on a national scale [8][9][10][11][12][13][14][15]. We herein contracted DeSC Healthcare, Inc. to use their dataset of national claim database.…”

Clinical practice and outcome of patients with elderly‐onset ulcerative colitis: Insights from a nationwide claims database study in Japan

“…On the contrary, a nationwide database, the so‐called big data, provides an adequate number of samples and enables the analysis of rare diseases and situations, such as those previously reported. 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 Therefore, this study aimed to clarify the clinical practice of EOUC and compare the differences in clinical course between EOUC and NEOUC using a nationwide claims database in Japan.…”

Effectiveness of Antibiotics for Uncomplicated Diverticulitis: A Retrospective Investigation Using a Nationwide Database in Japan

“…We have previously reported several studies using the Diagnosis Procedure Combination (DPC) nationwide database [6][7][8][9][10][11][12][13][14]. Use of the DPC, which contains a large amount of admission data, can facilitate clarification regarding the clinical practice of diverticulitis and evaluation of the efficacy of antibiotics.…”